lenalidomide has been researched along with Angiodysplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bull-Henry, K; Kessler, CM; Khatri, NV; Kohli, DR; Patel, B; Solomon, SS | 1 |
| Bowcock, SJ; Patrick, HE | 1 |
| Brouwer, RE; Heidt, J; Langers, AM; van der Meer, FJ | 1 |
3 other study(ies) available for lenalidomide and Angiodysplasia
| Article | Year |
|---|---|
Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease.
Topics: Aged; Angiodysplasia; Angiogenesis Inhibitors; Female; Humans; Lenalidomide; Male; Retrospective Studies; Thalidomide; von Willebrand Diseases | 2018 |
Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
Topics: Aged; Angiodysplasia; Angiogenesis Inhibitors; Chronic Disease; Female; Gastrointestinal Hemorrhage; Humans; Lenalidomide; Telangiectasia, Hereditary Hemorrhagic; Thalidomide | 2009 |
Thalidomide as treatment for digestive tract angiodysplasias.
Topics: Aged, 80 and over; Angiodysplasia; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Lenalidomide; Male; Melena; Recurrence; Thalidomide; Treatment Outcome; von Willebrand Diseases | 2006 |